Imdelltra Prices, Coupons, Copay Cards & Patient Assistance
Imdelltra (tarlatamab) is a member of the bispecific T-cell engagers (BiTE) drug class and is commonly used for Small Cell Lung Cancer.
The cost for Imdelltra dlle 1 mg intravenous powder for injection is around $1,589 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Imdelltra prices
Intravenous Powder For Injection
dlle 1 mg
Imdelltra intravenous powder for injection
from $1,589.00
for 1 powder for injection
Quantity | Per unit | Price |
---|---|---|
1 | $1,589.00 | $1,589.00 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
dlle 10 mg
Imdelltra intravenous powder for injection
from $15,804.50
for 1 powder for injection
Quantity | Per unit | Price |
---|---|---|
1 | $15,804.50 | $15,804.50 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Imdelltra Coupons, Copay Cards and Rebates
Imdelltra offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Imdelltra Amgen SupportPlus Co-Pay Program
Eligible commercially insured patients may pay as little as $0 per dose up to an annual maximum benefit per calendar year.
- Applies to:
- Imdelltra
- Number of uses:
- Per prescription until program expires
Patient Assistance & Copay Programs for Imdelltra
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Imdelltra (tarlatamab-dlle) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Amgen Safety Net Foundation (ASNF)
Eligibility requirements:- Must be uninsured or underinsured
- Varies
- Medically Necessary as determined by a Doctor
- Yes, must have lived in the US or its territories for 6 months or longer.
- Please visit (www.SafetyNetFoundation.com) (www.AmgenAssist360.com) for more information.
- Imdelltra (tarlatamab-dlle) Injection; IV
More information please phone: 888-762-6436 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Imdelltra (tarlatamab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español